Malignant Peritoneal Neoplasm Terminated Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00408070Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal CancerTreatment
NCT01821859Abraxane/BevacizumabTreatment